跳至主要内容
临床试验/NCT05280769
NCT05280769已完成不适用

Effects of an Oral Nicotine Product in Smokeless Tobacco Users

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年8月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
2
主要终点
Change in Plasma nicotine concentration

研究概览

简要总结

The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy (determined by self-report)
  • Between the ages of 18-55
  • Willing to provide informed consent, attend the lab sessions and abstain from tobacco/nicotine as required
  • Agree to use designated products according to study protocol
  • Smokeless tobacco users and must report using smokeless tobacco daily. Smokeless tobacco users must have a 'positive' cotinine cassette result to verify nicotine use

排除标准

  • The following self-reported current, diagnosed medical condition(s): heart-related conditions (e.g., recent heart attack/stroke, coronary heart disease), severe immune system disorders (e.g., HIV/AIDS, multiple sclerosis), respiratory disorders (e.g., COPD, asthma), kidney diseases, liver diseases (e.g., cirrhosis), or seizures
  • Other self-reported current, diagnosed medical conditions (e.g., diabetes, thyroid disease, Lyme disease) may be excluded after consultation with the PI and medical monitor: any medical condition/medication that may affect participant safety, study outcomes, or biomarker data will be excluded based on these consultations
  • Self-reported current, diagnosed psychiatric conditions, and who are currently under the care of a physician for psychiatric conditions, or who report current psychiatric treatment or psychotropic medication use
  • Not providing answers to questions related to inclusion/exclusion criteria
  • Breast-feeding or pregnant women (pregnancy tested by urinalysis at screening
  • Weigh less than 110 pounds
  • Intend to quit tobacco/nicotine use in the next 30 days

结局指标

主要结局

Change in Plasma nicotine concentration

时间窗: Baseline to the end of the session, approximately 4 hours

Blood will be taken multiple times in each session to assess the extent to which product use changes plasma nicotine levels compared to baseline

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验